Bardet-Biedl Syndrome 4 (BBS4) Peptide
BBS4
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN936262
Quick Overview for Bardet-Biedl Syndrome 4 (BBS4) Peptide (ABIN936262)
Target
BBS4
(Bardet-Biedl Syndrome 4 (BBS4))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- YVQALIFRLE GNIQESLELF QTCAVLSPQS ADNLKQVARS LFLLGKHKAA
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of BBS4 antibody,
Alternative Names: BBS4 control peptide, BBS4 antibody Blocking Peptide, Anti-BBS4 Blocking Peptide, Bardet-Biedl Syndrome 4 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- BBS4 (Bardet-Biedl Syndrome 4 (BBS4))
-
Background
- This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and mental retardation. The proteins encoded by BBS gene family members are structurally diverse. The similar phenotypes exhibited by mutations in BBS gene family members are likely due to the protein's shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport.
-
Molecular Weight
- 58 kDa
Target
-
You are here:
